These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11878118)

  • 81. Early prediction of response to intravenous iron supplementation by reticulocyte haemoglobin content and high-fluorescence reticulocyte count in haemodialysis patients.
    Chuang CL; Liu RS; Wei YH; Huang TP; Tarng DC
    Nephrol Dial Transplant; 2003 Feb; 18(2):370-7. PubMed ID: 12543894
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Repeated continuous administration of low doses of intravenous iron in anemic patients with active rheumatoid arthritis.
    Höchli P; Wagenhäuser FJ; Fehr J
    Eur J Haematol; 1993 Jul; 51(1):54-5. PubMed ID: 8348948
    [No Abstract]   [Full Text] [Related]  

  • 83. A randomized study of oral vs intravenous iron supplementation in patients with progressive renal insufficiency treated with erythropoietin.
    Stoves J; Inglis H; Newstead CG
    Nephrol Dial Transplant; 2001 May; 16(5):967-74. PubMed ID: 11328902
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Is IV iron sucrose a cost-effective option for treatment of severe anaemia in pregnancy as compared with oral iron?
    Ray S; Neogi SB; Singh R; Devasenapathy N; Zodpey S
    Health Policy Plan; 2021 Feb; 35(10):1339-1346. PubMed ID: 33230561
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Randomized controlled trial comparing ferric carboxymaltose and iron sucrose for treatment of iron deficiency anemia due to abnormal uterine bleeding.
    Mahey R; Kriplani A; Mogili KD; Bhatla N; Kachhawa G; Saxena R
    Int J Gynaecol Obstet; 2016 Apr; 133(1):43-8. PubMed ID: 26868063
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Fatal anaphylactic reaction to iron sucrose in pregnancy: iron-induced Kounis syndrome?
    Soufras GD; Kounis GN; Kounis NG
    Indian J Pharmacol; 2013; 45(6):642-3. PubMed ID: 24347784
    [No Abstract]   [Full Text] [Related]  

  • 87. Comparative rates of adverse events with different formulations of intravenous iron.
    Okam MM; Mandell E; Hevelone N; Wentz R; Ross A; Abel GA
    Am J Hematol; 2012 Nov; 87(11):E123-4. PubMed ID: 22965928
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants.
    Pollak A; Hayde M; Hayn M; Herkner K; Lombard KA; Lubec G; Weninger M; Widness JA
    Pediatrics; 2001 Jan; 107(1):78-85. PubMed ID: 11134438
    [TBL] [Abstract][Full Text] [Related]  

  • 89. New paradigms and therapies for iron replacement in iron deficiency anemia.
    Auerbach M
    Clin Adv Hematol Oncol; 2018 Nov; 16(11):712-715. PubMed ID: 30543585
    [No Abstract]   [Full Text] [Related]  

  • 90. [Difficulties of the care of public antigen alloimmunization].
    Ben Amor I; Rekik T; Louati N; Lahiani W; Rekik H; Peyrard T; Menif H; Gargouri J
    Transfus Clin Biol; 2016 May; 23(2):103-5. PubMed ID: 26826911
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Intravenous ferrous sucrose versus placebo in addition to oral iron therapy for the treatment of severe postpartum anaemia: a randomised controlled trial.
    Perelló MF; Coloma JL; Masoller N; Esteve J; Palacio M
    BJOG; 2014 May; 121(6):706-13. PubMed ID: 24423186
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Safety of ferric derisomaltose and iron sucrose in patients with iron deficiency anemia: The FERWON-IDA/NEPHRO trials.
    Wolf M; Auerbach M; Kalra PA; Glaspy J; Thomsen LL; Bhandari S
    Am J Hematol; 2021 Jan; 96(1):E11-E15. PubMed ID: 33027541
    [No Abstract]   [Full Text] [Related]  

  • 93. Rhabdomyolysis After Intravenous Iron Sucrose Infusion During Pregnancy.
    Ge C; Reyes J; Queenan RA; Gherman RB
    Obstet Gynecol; 2023 Jun; 141(6):1049-1051. PubMed ID: 37141585
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Iatrogenic osteomalacia: report of two cases.
    Yamamoto S; Okada Y; Mori H; Kurozumi A; Torimoto K; Arao T; Tanaka Y
    J UOEH; 2013 Mar; 35(1):25-31. PubMed ID: 23475021
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Autologous transfusion in a pregnant woman with anti-U and anti-He (Henshaw) antibodies].
    García Bueno MJ; Fernández Jiménez B; Muñiz-Díaz E; Parra López R
    Med Clin (Barc); 2005 May; 124(17):679. PubMed ID: 15882519
    [No Abstract]   [Full Text] [Related]  

  • 96. The immediate hematologic effects of intravenous saccharated iron oxide.
    WHITE LP; BIERMAN HR; KELLY KH; BYRON RL
    Blood; 1952 Sep; 7(9):897-903. PubMed ID: 14953947
    [No Abstract]   [Full Text] [Related]  

  • 97. Gelatinous bone marrow transformation complicated by self-induced malnutrition.
    Nonaka D; Tanaka M; Takaki K; Umeno M; Okamura T; Taketa H
    Acta Haematol; 1998; 100(2):88-90. PubMed ID: 9792939
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Staining of fungi with saccharated iron oxide.
    CIBIS PA; YAMASHITA T
    Stain Technol; 1959 May; 34(3):129-33. PubMed ID: 13659241
    [No Abstract]   [Full Text] [Related]  

  • 99. Staining of the retina with saccharated iron oxide.
    YAMASHITA T; CIBIS PA
    AMA Arch Ophthalmol; 1959 May; 61(5):698-708. PubMed ID: 13636564
    [No Abstract]   [Full Text] [Related]  

  • 100. Iron interventions in pregnancy and better clinical outcomes: the jury is out.
    Daru J
    Lancet Glob Health; 2019 Dec; 7(12):e1597-e1598. PubMed ID: 31708133
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.